Opinion|Videos|January 18, 2024

Academic Training and Advice for Clinicians Utilizing Rectal Spacers

Author(s)Brian Mazzarella, MD, Jeffrey T. Schiff, MD, MPH, Rizwan Nurani, MD

A group of urologists and radiation oncologists detail how they were trained on the utilization of rectal spacers and offer practical advice for other clinicians treating patients with prostate cancer.

Episodes in this series

A panel of 5 experts on prostate cancer

EP. 1 Radiation Safety Considerations for Patients With Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 2 Urology Perspective on Radiation Toxicity in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 3 SBRT and Hypofractionation in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 4 Prostate Cancer: Best Candidates for Rectal Spacing

A panel of 5 experts on prostate cancer

EP. 5 Rectal Spacing With Proton Therapy and Brachytherapy in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 6 Patient-Centric Approach in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 7 Challenges and Complications With Rectal Spacing in Prostate Cancer

Varun Sundaram, MD, an expert on prostate cancer

EP. 8 Prostate Cancer: Hyaluronic Acid Spacers

Rizwan Nurani, MD, an expert on prostate cancer

EP. 9 Balloon Spacers in Prostate Cancer

Jeffrey T. Schiff, MD, MPH, an expert on prostate cancer

EP. 10 The Role of PEG Hydrogel Spacers in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 11 Prostate Cancer Treatment: Visibility Considerations With Radiation

A panel of 5 experts on prostate cancer

EP. 12 Pros and Cons of Rectal Spacer Types in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 13 Clinical Trials Investigating Rectal Spacers in Prostate Cancer

A panel of 5 experts on prostate cancer

EP. 14 Multidisciplinary Care in Prostate Cancer Treatment

A panel of 5 experts on prostate cancer

EP. 15 Rectal Spacers: Placement, Complications, and Management

A panel of 5 experts on prostate cancer

EP. 16 Academic Training and Advice for Clinicians Utilizing Rectal Spacers

A panel of 5 experts on prostate cancer

EP. 17 Future Landscape of Prostate Cancer and Rectal Spacers

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD

ByAdam B. Weiner, MD,Tyler Seibert, MD, PhD

August 21st 2026

Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care

ByMary Dunn, MSN, NP-C, OCN, RN

August 20th 2026

SBRT improves multiple quality of life domains but not DFS vs MH-IMRT

ByHannah Clarke

August 18th 2026

Active surveillance use for low-risk prostate cancer reaches 93% in VA system

ByHannah Clarke

August 14th 2026

Focal therapy for prostate cancer frequently used outside guideline-supported groups

ByHannah Clarke

August 14th 2026

Latest CME

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom

FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent

Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care

The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD

Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy